Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Mulan, Chen"'
Autor:
Fan Wu, Nani Li, Xiufeng Wu, Mulan Chen, Weiwei Huang, Xinhua Chen, Yi Hong, Lili Wang, Kan Chen, Lin Lin, Minjin You, Jian Liu
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background The prognosis of breast cancer patients with visceral metastasis (VM) is significantly worse than that of patients without VM. We aimed to evaluate EZH2 (enhancer of zeste homolog 2) mutation as a biomarker associated with VM. Met
Externí odkaz:
https://doaj.org/article/38b6e4869a3344e6a7c3747477a45b49
Publikováno v:
Genes and Diseases, Vol 12, Iss 2, Pp 101429- (2025)
Parkinson's disease (PD) is a neurodegenerative disorder characterized by fibrillar neuronal inclusions containing aggregated α-synuclein (α-Syn). While the pathology of PD is multifaceted, the aggregation of α-Syn and mitochondrial dysfunction ar
Externí odkaz:
https://doaj.org/article/d6db733e7f5140a88ffefb13650afd93
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundThis study aimed to assess the cost-effectiveness of combining utidelone with capecitabine, compared to capecitabine monotherapy, for the treatment of anthracycline- and taxane-refractory metastatic breast cancer within the Chinese healthca
Externí odkaz:
https://doaj.org/article/dee1e324d4a9483eaf9d1fcfe77470ff
Autor:
Weiwei Huang, Chenxi Wang, Yangkun Shen, Qi Chen, Zhijian Huang, Jian Liu, Xiaoyan Lin, Lili Wang, Fan Wu, Xinhua Chen, Nani Li, Yi Hong, Mulan Chen, Jieyu Li, Chuanzhong Huang
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Purpose This investigation sought to examine the efficacy and safety of low-dose apatinib used alongside chemotherapy in the clinical management of patients with metastatic triple-negative breast cancer (TNBC) within a real-world setting, wh
Externí odkaz:
https://doaj.org/article/1811507d7f064e97bfcf84e87ab838f3
Autor:
Weiwei Huang, Chenxi Wang, Lili Wang, Yangkun Shen, Qi Chen, Zhijian Huang, Jian Liu, Xiaoyan Lin, Fan Wu, Xinhua Chen, Nani Li, Yi Hong, Mulan Chen, Jieyu Li, Chuanzhong Huang
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
Background: Patients with Triple-negative breast cancer (TNBC) face a poor prognosis and limited therapeutic options. Current data on eribulin usage to treat TNBC is scarce. Therefore, we sought to compare the feasibility and tolerability of eribulin
Externí odkaz:
https://doaj.org/article/5b0917ecc0b043ea981d1fb93407a6ba
Publikováno v:
Genes and Diseases, Vol 10, Iss 3, Pp 1062-1074 (2023)
Disrupting the balance of neuronal excitation and inhibition (E/I) is an important pathogenic mechanism of anxiety and depression. Interferon regulatory factor 3 (IRF3) plays a key role in the innate immune response, and activation of IRF3 triggers t
Externí odkaz:
https://doaj.org/article/fce1e2e1e34248098b086920592da72e
Autor:
Weiwei Huang, Chenxi Wang, Yangkun Shen, Qi Chen, Zhijian Huang, Jian Liu, Xiaoyan Lin, Lili Wang, Fan Wu, Xinhua Chen, Nani Li, Yi Hong, Mulan Chen, Jieyu Li, Chuanzhong Huang
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/80e3bf59f3f44d12a265d73dfa41a059
Autor:
Mengsong Liu, Wenyuan Li, Xiao Ma, Yuhui Che, Bo Wei, Mulan Chen, Lin Zhong, Siqi Zhao, Anjing Chen, Yaobin Pang, Jinhao Zeng, Jing Guo
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
BackgroundImmune checkpoint inhibitors (ICIs) have revolutionized metastatic melanoma (MM) treatment in just a few years. Ultraviolet (UV) in sunlight is the most significant environmental cause of melanoma, which is considered to be the main reason
Externí odkaz:
https://doaj.org/article/9a703d60c7554268b37af888f0e6d7b2
Publikováno v:
Frontiers in Pharmacology; 2024, p1-13, 13p
Publikováno v:
Science of Advanced Materials. 14:829-835
Nab-paclitaxel is a water-soluable formulation of paclitaxel. It is more effective and less toxic than paclitaxel in treating cancer. Here we compared nab-paclitaxel with paclitaxel for their antitumor efficacy and toxicity in vitro and in a murine e